University of Oklahoma College of Medicine researcher Carol Webb, Ph.D., has earned a National Institutes of Health grant to continue her studies of ARID3a, a protein that may help explain why lupus ...

InvestigateTV+ shares a young mother’s struggle with the debilitating effects of lupus. Plus, we take an in-depth look at what could become a breakthrough treatment.

A new study examined whether urinary biomarkers could predict future kidney complications in individuals with lupus nephritis ...

Nipocalimab, an FcRn blocker, receives FDA Fast Track status for SLE treatment after demonstrating significant improvements in disease activity.

Johnson & Johnson has won U.S. Food and Drug Administration fast-track designation for its investigational nipocalimab drug in adults with systemic lupus erythematosus, a chronic autoimmune disease.

This International Women’s Day, Starbucks Bahamas will recognize the strength, resilience, and everyday courage of women across the country who are living with lupus. Guided by this year’s message, “I ...